Enovis (ENOV) Depreciation & Amortization (CF) (2011 - 2026)
Enovis (ENOV) posted quarterly Depreciation & Amortization (CF) of $73.4 million for Q2 2026, up 2.69% year-over-year from $71.4 million in Q2 2025, and down 4.75% quarter-over-quarter from $77.0 million in Q4 2025.
Enovis (ENOV) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends
Enovis (ENOV) has reported Depreciation & Amortization (CF) for 16 consecutive years, with $73.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) rose 2.69% year-over-year to $73.4 million; the TTM figure through Apr 2026 stood at $296.3 million (up 4.76% YoY), while the FY2025 annual figure was $294.4 million, up 3.36% from the prior year.
- Depreciation & Amortization (CF) slipped to $73.4 million in Q2 2026 per ENOV's latest filing, from $77.0 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $97.4 million in Q2 2023 and bottomed at $7.6 million in Q1 2023.
- Historically, Depreciation & Amortization (CF) has averaged $64.1 million across 5 years, with a median of $71.2 million in 2024.
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) plunged 88.48% — and 2024, when it surged 865.08%.
- Enovis' Depreciation & Amortization (CF) stood at $52.3 million in 2022, then grew by 8.34% to $56.6 million in 2023, then jumped by 31.42% to $74.4 million in 2024, then climbed by 3.51% to $77.0 million in 2025, then decreased by 4.75% to $73.4 million in 2026.
- Business Quant data shows ENOV's Depreciation & Amortization (CF) at $73.4 million in Q2 2026, $77.0 million in Q4 2025, and $74.4 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Enovis | 1.51 Bn | 1.50 Bn | 359.25 Mn | 71.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 71.03 Mn |
| Jul 3, 2026 | 71.03 Mn |
| Apr 3, 2026 | 73.36 Mn |
| Apr 3, 2026 | 73.36 Mn |
| Dec 31, 2025 | 77.01 Mn |
| Dec 31, 2025 | 77.01 Mn |
| Oct 3, 2025 | 74.38 Mn |
| Oct 3, 2025 | 74.38 Mn |
| Jul 4, 2025 | 71.55 Mn |
| Jul 4, 2025 | 71.55 Mn |
| Apr 4, 2025 | 71.44 Mn |
| Apr 4, 2025 | 71.44 Mn |
| Dec 31, 2024 | 74.40 Mn |
| Dec 31, 2024 | 74.40 Mn |
| Sep 27, 2024 | 71.23 Mn |
| Sep 27, 2024 | 71.23 Mn |
| Jun 28, 2024 | 65.76 Mn |
| Jun 28, 2024 | 65.76 Mn |
| Mar 29, 2024 | 73.40 Mn |
| Mar 29, 2024 | 73.40 Mn |